常山药业
(300255)
| 流通市值：217.39亿 | | | 总市值：217.73亿 |
| 流通股本：9.18亿 | | | 总股本：9.19亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 475,824,544.14 | 256,104,391.71 | 875,132,346.58 | 681,221,459.23 |
| 营业总成本 | 504,881,082.96 | 258,653,057.22 | 1,068,085,647.98 | 764,791,820.51 |
| 其他经营收益 | | | | |
| 营业利润 | -19,620,766.83 | 4,745,773.24 | -350,312,893.45 | -54,677,756.56 |
| 利润总额 | -19,171,707.32 | 5,202,914.84 | -355,891,602.55 | -54,340,210.45 |
| 净利润 | -21,756,068.81 | 3,380,404.27 | -367,461,129.51 | -56,983,632.04 |
| 每股收益 | | | | |
| 其他综合收益 | 211,499.49 | 132,930.07 | -219,716.12 | -254,189.96 |
| 综合收益总额 | -21,544,569.32 | 3,513,334.34 | -367,680,845.63 | -57,237,822 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,820,224,289.31 | 1,777,930,137.9 | 1,712,288,754.52 | 2,077,304,073.35 |
| 非流动资产: | | | | |
| 非流动资产合计 | 2,668,443,968.61 | 2,660,571,184.82 | 2,638,900,835.26 | 2,580,280,515.63 |
| 资产总计 | 4,488,668,257.92 | 4,438,501,322.72 | 4,351,189,589.78 | 4,657,584,588.98 |
| 流动负债: | | | | |
| 流动负债合计 | 2,442,238,134.17 | 2,396,492,275.23 | 2,484,300,831.66 | 2,384,441,070.63 |
| 非流动负债: | | | | |
| 非流动负债合计 | 899,916,267.85 | 870,437,287.93 | 698,830,332.9 | 794,642,069.5 |
| 负债合计 | 3,342,154,402.02 | 3,266,929,563.16 | 3,183,131,164.56 | 3,179,083,140.13 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,187,593,136.25 | 1,210,147,369.49 | 1,204,143,419.49 | 1,517,187,110.58 |
| 股东权益合计 | 1,146,513,855.9 | 1,171,571,759.56 | 1,168,058,425.22 | 1,478,501,448.85 |
| 负债和股东权益合计 | 4,488,668,257.92 | 4,438,501,322.72 | 4,351,189,589.78 | 4,657,584,588.98 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 457,872,662.97 | 236,839,987.81 | 966,744,715.81 | 809,019,510.33 |
| 经营活动现金流出小计 | 437,278,767.67 | 216,631,836.19 | 911,061,837.5 | 666,668,760.48 |
| 经营活动产生的现金流量净额 | 20,593,895.3 | 20,208,151.62 | 55,682,878.31 | 142,350,749.85 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 168,061,000 | 100,020,000 | 157,263,980 | 106,503,980 |
| 投资活动现金流出小计 | 235,599,304.05 | 129,444,247.04 | 280,574,028.04 | 178,605,176.77 |
| 投资活动产生的现金流量净额 | -67,538,304.05 | -29,424,247.04 | -123,310,048.04 | -72,101,196.77 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 1,674,490,551.29 | 824,214,751.29 | 2,611,784,918.63 | 2,068,038,918.63 |
| 筹资活动现金流出小计 | 1,580,457,015.68 | 758,850,219.9 | 2,670,328,685.58 | 2,129,897,694.01 |
| 筹资活动产生的现金流量净额 | 94,033,535.61 | 65,364,531.39 | -58,543,766.95 | -61,858,775.38 |
| 汇率变动对现金及现金等价物的影响 | -995,274.74 | -729,624.2 | 2,282,864.87 | 2,765,798.57 |
| 现金及现金等价物净增加额 | 46,093,852.12 | 55,418,811.77 | -123,888,071.81 | 11,156,576.27 |
| 期末现金及现金等价物余额 | 158,092,560.93 | 167,417,520.58 | 111,998,708.81 | 247,043,356.89 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 46,093,852.12 | - | -123,888,071.81 | - |